Log in
Enquire now

List of ViiV Healthcare patents

List of ViiV Healthcare patents
List of Hirosaki University patents
List of Jinan University patents
List of Aston University patents
Films directed by Preston Sturges
List of companies in Company K Partners's investment portfolio
Patents where
Current Assignee
Name
is
ViiV HealthcareViiV Healthcare
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10245275 Triterpenoids with HIV maturation inhibitory activity

Patent 10245275 was granted and assigned to ViiV Healthcare on April, 2019 by the United States Patent and Trademark Office.

‌
Viiv Healthcare UK (No.4) Limited
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10245275
April 2, 2019
‌
US Patent 11084845 C-3 and C-17 modified triterpenoids as HIV-1 inhibitors

Patent 11084845 was granted and assigned to ViiV Healthcare on August, 2021 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
11084845
August 10, 2021
‌
US Patent 10035760 Inhibitors of human immunodeficiency virus replication

Patent 10035760 was granted and assigned to ViiV Healthcare on July, 2018 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10035760
July 31, 2018
‌
US Patent 10125148 Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication

Patent 10125148 was granted and assigned to ViiV Healthcare on November, 2018 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10125148
November 13, 2018
‌
US Patent 10189816 Substituted pyridines as inhibitors of human immunodeficiency virus replication

Patent 10189816 was granted and assigned to ViiV Healthcare on January, 2019 by the United States Patent and Trademark Office.

‌
Viiv Healthcare UK (No.5) Limited
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10189816
January 29, 2019
‌
US Patent 9932356 Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication

Patent 9932356 was granted and assigned to ViiV Healthcare on April, 2018 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
9932356
April 3, 2018
‌
US Patent 9637501 Pyridin-3-yl acetic acid macrocycles as inhibitors of human immunodeficiency virus replication

Patent 9637501 was granted and assigned to ViiV Healthcare on May, 2017 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
9637501
May 2, 2017
‌
US Patent 9932353 Imidazopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication

Patent 9932353 was granted and assigned to ViiV Healthcare on April, 2018 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
9932353
April 3, 2018
‌
US Patent 9505752 Piperidine amide derivatives as HIV attachment inhibitors

Patent 9505752 was granted and assigned to ViiV Healthcare on November, 2016 by the United States Patent and Trademark Office.

Bristol-Myers Squibb
Bristol-Myers Squibb
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
9505752
November 29, 2016
‌
US Patent 8889877 Processes for preparing pyridinone carboxylic acid aldehydes

Patent 8889877 was granted and assigned to ViiV Healthcare on November, 2014 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
8889877
November 18, 2014
‌
US Patent 10351546 Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Patent 10351546 was granted and assigned to ViiV Healthcare on July, 2019 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10351546
July 16, 2019
‌
US Patent 10780102 Triterpenoids with HIV maturation inhibitory activity

‌
Viiv Healthcare UK (No.4) Limited
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10780102
September 22, 2020
‌
US Patent 11224597 Pharmaceutical compositions

Patent 11224597 was granted and assigned to ViiV Healthcare on January, 2022 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
11224597
January 18, 2022
‌
US Patent 10493070 Azadecalin derivatives as inhibitors of human immunodeficiency virus replication

Patent 10493070 was granted and assigned to ViiV Healthcare on December, 2019 by the United States Patent and Trademark Office.

ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare
United States Patent and Trademark Office
United States Patent and Trademark Office
10493070
December 3, 2019
14 results
0 selected
14 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us